Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPanthera Res. Regulatory News (PAT)

Share Price Information for Panthera Res. (PAT)

Share Price is delayed by 15 minutes
Get Live Data
18.50    -0.10 (-0.55%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £47.12m
PAT Live PriceLast checked at - London Stock Exchange

Intraday Panthera Res. Share Chart

Total Voting Rights

31 Jan 2025 16:45

RNS Number : 5016V
Panthera Resources PLC
31 January 2025
 

31 January 2025

 

Panthera Resources Plc

("Panthera" or the "Company")

 

Total Voting Rights

 

Gold exploration and development company Panthera Resources Plc (AIM: PAT), with assets in West Africa and India, announces that the Company's issued share capital as at the date of this announcement comprises 198,101,247 ordinary shares of 1 pence each with one voting right per share ("Ordinary Shares"). The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary Shares and voting rights in the Company is 198,101,247.

 

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of the Company under the Disclosure Guidance and Transparency Rules of the UK Financial Conduct Authority.

 

Contacts

 

Panthera Resources PLC

Mark Bolton (Managing Director) +61 411 220 942

contact@pantheraresources.com

 

Allenby Capital Limited (Nominated Adviser & Joint Broker) +44 (0) 20 3328 5656

John Depasquale / Vivek Bhardwaj (Corporate Finance)

Guy McDougall / Kelly Gardiner

 

VSA Capital Limited (Joint Broker) +44 (0) 20 3005 5000

Andrew Monk / Andrew Raca

 

Novum Securities Limited (Joint Broker) +44 (0) 20 7399 9400

Colin Rowbury

 

Subscribe for Regular Updates

 

Follow the Company on Twitter at @PantheraPLC

 

For more information and to subscribe to updates visit: pantheraresources.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRGZGFMFMMGKZM
Date   Source Headline
3rd Jun 20267:00 amRNS-ROnline Investor Webinar
29th May 20265:15 pmRNSTotal Voting Rights
21st May 20267:00 amRNSConversion of Options
6th May 20267:00 amRNSConversion of Options
30th Apr 20265:00 pmRNSTotal Voting Rights
14th Apr 20267:09 amRNSConversion of Options
9th Apr 20262:31 pmRNSIssue of Equity – In Lieu of Director Fees
2nd Mar 20267:00 amRNSArbitration Update
19th Jan 20267:00 amRNSBido Drilling Results
31st Dec 202512:45 pmRNSTotal Voting Rights
31st Dec 202512:45 pmRNSTotal Voting Rights
29th Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20257:00 amRNSHalf-year Financial Report
11th Dec 20257:00 amRNSWarrant Conversion
3rd Dec 20257:00 amRNSWarrant Conversion
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20258:59 amRNSWarrant Conversion
21st Nov 20257:00 amRNSKalaka Metallurgical Study Results
20th Nov 20252:00 pmRNSWarrant Conversion
17th Nov 20257:00 amRNSOTCQB Approval
12th Nov 20257:00 amRNSOTC Application
3rd Nov 202511:02 amRNSIssue of Equity - Warrant Conversion and Fees
31st Oct 20255:05 pmRNSTotal Voting Rights
29th Oct 20257:00 amRNSArbitration Update
16th Oct 20255:05 pmRNSWarrant Conversion
9th Oct 202510:31 amRNSWarrant Conversion
8th Oct 20257:00 amRNSArbitration Financing Facility Update
3rd Oct 202511:30 amRNSResult of AGM
29th Sep 20257:00 amRNSChange of Registered Office
18th Sep 20257:00 amRNSArbitration Update
29th Aug 20255:00 pmRNSTotal Voting Rights
27th Aug 20257:58 amRNS2025 Annual Financial Report
8th Aug 20257:00 amRNSOption Conversion
4th Aug 20257:00 amRNSCommencement of Cascades Feasibility Study
25th Jul 20257:32 amRNSWarrant Conversion
18th Jul 20257:00 amRNSBido Drilling
19th May 20257:00 amRNSUS$1.58 billion Claim for Damages
30th Apr 20255:00 pmRNSTotal Voting Rights
16th Apr 20253:54 pmRNSIssue of Equity - Warrant Conversion and Fees
31st Mar 20255:00 pmRNSTotal Voting Rights
27th Mar 20257:00 amRNSIssue of Equity - Conversion of Options
20th Mar 202510:37 amRNSWarrant Exercise
7th Mar 20255:35 pmRNSNotification of Major Holding
6th Mar 20254:45 pmRNSUpdate on Issue of Equity Fundraising
28th Feb 20255:32 pmRNSNotification of Major Holding
25th Feb 20257:47 amRNSResult of Placing and Subscription
24th Feb 20255:04 pmRNSIssue of Equity
21st Feb 20255:00 pmRNSWarrant Exercise
20th Feb 20256:11 pmRNSNotifications of Major Holdings
4th Feb 20257:00 amRNSMaiden JORC Resource Estimate for Kalaka Project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.